11 – 20 of 114
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
Usage and usability of a national e-library for chemotherapy regimens: a mixed method study
(
- Contribution to journal › Article
-
Mark
Molecular Subtypes as a Basis for Stratified Use of Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer—A Narrative Review
(
- Contribution to journal › Scientific review
-
Mark
Testicular Dysfunction Among Cancer Survivors
(
- Contribution to journal › Scientific review
-
Mark
Intralesional margin after excision of a high-grade osteosarcoma : Is it a catastrophe?
(
- Contribution to journal › Article
-
Mark
HMGA1 has predictive value in response to chemotherapy in gastric cancer
(
- Contribution to journal › Article
-
Mark
Different Responses to Neoadjuvant Chemotherapy in Urothelial Carcinoma Molecular Subtypes
(
- Contribution to journal › Article
- 2021
-
Mark
Newly diagnosed and relapsed follicular lymphoma : ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2021) In Annals of oncology : official journal of the European Society for Medical Oncology 32(3). p.298-308(
- Contribution to journal › Article
-
Mark
Randomized Phase II trial of combination chemotherapy with panitumumab or bevacizumab for patients with inoperable biliary tract cancer without KRAS exon 2 mutations
(
- Contribution to journal › Article
-
Mark
Thromboembolism in Muscle-Invasive Bladder Cancer. A Population-based Nationwide Study
(
- Contribution to journal › Article
-
Mark
Curcuma as an adjuvant in colorectal cancer treatment
(
- Contribution to journal › Article